SAN DIEGO, Sept. 10, 2013 /PRNewswire/ -- Solulink, Inc., an emerging life science tools company with expertise in biomolecular linking, announced today that Jack Ball has been appointed as the company's Chief Executive Officer. A proven performer, Mr. Ball will lead the company as it commercializes its HybriLink™ technology.
The HybriLink technology solves the 'missing color' problem: the inability to find the needed antibody labeled with the right fluorophore (color). Often, the desired combination is not commercially available. By providing a simple way to mix and match any fluorophore with any antibody on demand, just-in-time at the point-of-use, HybriLink dramatically streamlines the development and expansion of multicolor flow panels for flow cytometry research labs. Solulink believes that HybriLink's ability to offer all antibodies in all fluorophores – including the next generation of emerging fluorophores – resolves a fundamental challenge in flow cytometry and will expand the overall flow cytometry reagents market size. The HybriLink technology also provides increased flexibility in antibody labeling to the microscopy, western blot and ELISA markets.
Mr. Ball brings a solid track record of life sciences leadership with a strong background in commercial operations, and extensive experience in the life science markets. Most recently, he served as Chief Commercial Officer at Accuri Cytometers, Inc., before its acquisition by BD Biosciences in 2011. Prior to joining Accuri, Mr. Ball was CEO of Amnis Corporation, a venture-backed, technology start-up developing high-end imaging flow cytometers. He also served as Chief Commercial Officer for Molecular Probes, Inc. (now a part of Life Technologies), the world lead
|SOURCE Solulink, Inc.|
Copyright©2012 PR Newswire.
All rights reserved